Cargando…

Characterization of Patients with Pulmonary Arterial Hypertension: Data from the Polish Registry of Pulmonary Hypertension (BNP-PL)

Current knowledge of pulmonary arterial hypertension (PAH) epidemiology is based mainly on data from Western populations, and therefore we aimed to characterize a large group of Caucasian PAH adults of Central-Eastern European origin. We analyzed data of incident and prevalent PAH adults enrolled in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kopeć, Grzegorz, Kurzyna, Marcin, Mroczek, Ewa, Chrzanowski, Łukasz, Mularek-Kubzdela, Tatiana, Skoczylas, Ilona, Kuśmierczyk, Beata, Pruszczyk, Piotr, Błaszczak, Piotr, Lewicka, Ewa, Karasek, Danuta, Mizia-Stec, Katarzyna, Tomaszewski, Michał, Jacheć, Wojciech, Ptaszyńska-Kopczyńska, Katarzyna, Peregud-Pogorzelska, Małgorzata, Doboszyńska, Anna, Pawlak, Agnieszka, Gąsior, Zbigniew, Zabłocka, Wiesława, Ryczek, Robert, Widejko-Pietkiewicz, Katarzyna, Waligóra, Marcin, Darocha, Szymon, Furdal, Michał, Ciurzyński, Michał, Kasprzak, Jarosław D., Grabka, Marek, Kamiński, Karol, Hoffman, Piotr, Podolec, Piotr, Torbicki, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019268/
https://www.ncbi.nlm.nih.gov/pubmed/31936377
http://dx.doi.org/10.3390/jcm9010173
Descripción
Sumario:Current knowledge of pulmonary arterial hypertension (PAH) epidemiology is based mainly on data from Western populations, and therefore we aimed to characterize a large group of Caucasian PAH adults of Central-Eastern European origin. We analyzed data of incident and prevalent PAH adults enrolled in a prospective national registry involving all Polish PAH centers. The estimated prevalence and annual incidence of PAH were 30.8/mln adults and 5.2/mln adults, respectively and they were the highest in females ≥65 years old. The most frequent type of PAH was idiopathic (n = 444; 46%) followed by PAH associated with congenital heart diseases (CHD-PAH, n = 356; 36.7%), and PAH associated with connective tissue disease (CTD-PAH, n = 132; 13.6%). At enrollment, most incident cases (71.9%) were at intermediate mortality risk and the prevalent cases had most of their risk factors in the intermediate or high risk range. The use of triple combination therapy was rare (4.7%). A high prevalence of PAH among older population confirms the changing demographics of PAH found in the Western countries. In contrast, we found: a female predominance across all age groups, a high proportion of patients with CHD-PAH as compared to patients with CTD-PAH and a low use of triple combination therapy.